According to Griffon Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company Sr VP, Gen. Counsel and Secy, Kaplan Seth L. disclosed selling 17,909 shares at a cost of $23.98. At the time of this transaction (Feb 04), this trade was worth […]
According to Griffon Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 05:03 PM, company Sr VP, Gen. Counsel and Secy, Kaplan Seth L. disclosed selling 9,737 shares at a cost of $23.62. At the time of this transaction (Feb 03), this trade was worth […]
According to Denali Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:44 PM, company EVP, Chief Commercial Officer, Schuth Alexander O. disclosed selling 10,000 shares at a cost of $67.84. At the time of this transaction (Feb 04), this trade was worth $678,361 […]
According to Vertex Pharmaceuticals Inc / Ma’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:43 PM, company Director, Arbuckle Stuart A disclosed selling 1,554 shares at a cost of $213.74. At the time of this transaction (Feb 03), this trade was worth $332,146 in […]
According to Blackline, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:43 PM, company President & CEO, Smith Graham disclosed selling 8,000 shares at a cost of $140.43. At the time of this transaction (Feb 04), this trade was worth $1,123,409 in total. As […]
According to Epizyme, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:41 PM, company Director, Bazemore Robert B disclosed selling 3,890 shares at a cost of $11.21. At the time of this transaction (Feb 04), this trade was worth $43,607 in total. As of […]
According to Allegiant Travel Co’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:41 PM, company Chief Medical Officer, Ellmer Gary disclosed selling 450 shares at a cost of $220.10. At the time of this transaction (Feb 05), this trade was worth $99,045 in total. […]
According to Epizyme, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:41 PM, company Chief Financial Officer, Agarwal Shefali disclosed selling 969 shares at a cost of $11.21. At the time of this transaction (Feb 04), this trade was worth $10,862 in total. As […]
According to Epizyme, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:40 PM, company Corporate Controller, Tombesi Paolo disclosed selling 1,021 shares at a cost of $11.21. At the time of this transaction (Feb 04), this trade was worth $11,445 in total. As of […]
According to Koss Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 05 04:39 PM, company Vice President – Sales, Koss John C Jr disclosed selling 5,000 shares at a cost of $24.00. At the time of this transaction (Feb 04), this trade was worth $120,000 […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
